1. Harata G, He F, Hiruta N, Kawase M, Kubota A, Hiramatsu M, et al. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol. 2010. 50:597–602.
Article
2. Kawase M, He F, Kubota A, Harata G, Hiramatsu M. Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. Lett Appl Microbiol. 2010. 51:6–10.
Article
3. Ben-Yedidia T, Arnon R. Epitope-based vaccine against influenza. Expert Rev Vaccines. 2007. 6:939–948.
Article
4. LaRussa P. Pandemic novel 2009 H1N1 influenza: what have we learned? Semin Respir Crit Care Med. 2011. 32:393–399.
Article
6. Shin SY, Kang C, Gwack J, Kim JH, Kim HS, Kang YA, et al. Drug-resistant pandemic (H1N1) 2009, South Korea. Emerg Infect Dis. 2011. 17:702–704.
7. Cho M, Chung H, Choi W, Yoon J. Linear correlation between inactivation of
E. coli and OH radical concentration in TiO
2 photocatalytic disinfection. Water Res. 2004. 38:1069–1077.
Article
8. Ditta IB, Steele A, Liptrot C, Tobin J, Tyler H, Yates HM, et al. Photocatalytic antimicrobial activity of thin surface films of TiO(2), CuO and TiO(2)/CuO dual layers on
Escherichia coli and bacteriophage T4. Appl Microbiol Biotechnol. 2008. 79:127–133.
Article
9. Sang X, Phan TG, Sugihara S, Yagyu F, Okitsu S, Maneekarn N, et al. Photocatalytic inactivation of diarrheal viruses by visible-light-catalytic titanium dioxide. Clin Lab. 2007. 53:413–421.